N
Google TrendANNA BONDAR (200+) — October 11, 2026: Lilli Tagger vs Nikola Bartunkova: Set 1 Winner Prediction Market
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:anna bondar200+natanael cano100+green card500+power outage near me10000+india2000+sony playstation1000+loki100+hubert hurkacz200+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "New targeted combination" (30 stories)

Top Headline Story

CLL Treatment Enters a New Era of Targeted Combinations
Lead StoryTargeted Oncologygeneral
3d ago

CLL Treatment Enters a New Era of Targeted Combinations

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxQbDNfak9mLU5MQW9yWE9rblNrd3U1RWQtbjlaOWhpOTJpTG9yamszMlBNeFJjQ1AwRnFEeS1GUE5xUlJxc01IQVZJNGpMMXg1bTljaW4xLVpnRmtrRExVUjBiZk5nR292QWNtSE01c1lrODkyNU9QVUtQQ18xMVJhUGM0d01BVnhYUXlnNzZIWTFOSW1sSFpDQjdVUFEzZw?oc=5" target="_blank">CLL Treatment Enters a New Era of Targeted Combinations</a>  <font color="#6f6f6f">Targeted Oncology</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
200+16m ago

anna bondar

October 11, 2026: Lilli Tagger vs Nikola Bartunkova: Set 1 Winner Prediction Market

Filter stories
100+16m ago

natanael cano

Padres de Natanael Cano rompen el silencio tras retiro del cantante: "Es por el bien de nuestro hijo"

Filter stories
500+26m ago

green card

Vance says Microsoft replaced laid-off workers with foreign hires. Here’s what the visa data shows

Filter stories
10000+26m ago

power outage near me

LIVE | Atlanta weather: Power outages, tree damage remain as storm threat moves east

Filter stories

Search Results for "New targeted combination"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Combination of targeted therapies could help overcome treatment resistance in advanced prostate cancer
UCLA Healthgeneral

Combination of targeted therapies could help overcome treatment resistance in advanced prostate cancer

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxQNnRXd2IwZXNZYzlrRmRzX3pmOUcxNVJlalRvWjhBelJMdDJ0ZDdZdnUyYjJSZkdHUVVmVk1Ia3YxM3lWUmpfOWdTZ2NrZTVTV3hWbnZtSmxLeFVxZy1fQWhOSkNRZXVhMHVoZTE2QkFBN08zM2E3WGt0OTBuejhISXZEdkVmb3VxSXNQZE5zZ0Q1aU5HWmp6b2hZNDZ2T1NvZVE?oc=5" target="_blank">Combination of targeted therapies could help overcome treatment resistance in advanced prostate cancer</a>  <font color="#6f6f6f">UCLA Health</font>

Read Full StoryMore like this
Roswell Park-Led Study Shows Promise for New Targeted Combination in People With Relapsed AML
Roswell Park Comprehensive Cancer Centergeneral

Roswell Park-Led Study Shows Promise for New Targeted Combination in People With Relapsed AML

<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxNOUxNNEdzTmxXOWt3d0RReEY1cS1CRmJlZ2RqUHFkdFRlSUZCY0VBUnJ0LTk3SXF5TVRhay01eEVxUS1kNVdyMUNxVHZ1NmI5d2RCQ2Q5NzV2VTNvQlVSa3JEQ25DZklnZlg2YkItVjhDR1RPTXRQbzNjUkZKVTNTR0pRejNfSGpIeUVWTVh1aTN6MFRZRVNrNnhrMFJJejE4d3NMODNGTVhZemE3LUdvSmpNZ3oycWtNQjY0TWlzamo5RGc?oc=5" target="_blank">Roswell Park-Led Study Shows Promise for New Targeted Combination in People With Relapsed AML</a>  <font color="#6f6f6f">Roswell Park Comprehensive Cancer Center</font>

Read Full StoryMore like this
ASCO: Targeted therapy combo nearly doubles time without disease progression for patients with advanced colorectal cancer
UT MD Andersongeneral

ASCO: Targeted therapy combo nearly doubles time without disease progression for patients with advanced colorectal cancer

<a href="https://news.google.com/rss/articles/CBMi0wFBVV95cUxONDFhNmQ4cWt5dDdCM3E2NnhyREJ4cFJUd1d3QThja29mdTBxMEEzRVJERDRPTVlSVDYxaVM5NUVLU2VYSVkwU3hlejBwNk5nSHh1VnZ1Mk92SmJERDB1TG9kcGhjdFMyOVMxQk5KS0hnLVd5aF9yRmhhZDE0Y3dmZjhtbXY3ZFNUbVRCVUVSYmdOOTNTMk1IODE5LVBrVzA1TmJLTlk5eDBfU1RVemY4TWxVRVczVmc3eFFSN1pjb21EWWZjVUE0YWlYMzl2M3NRY1hv?oc=5" target="_blank">ASCO: Targeted therapy combo nearly doubles time without disease progression for patients with advanced colorectal cancer</a>  <font color="#6f6f6f">UT MD Anderson</font>

Read Full StoryMore like this
Combination therapy doubles one-year survival in pancreatic cancer trial
Drug Discovery Newsgeneral

Combination therapy doubles one-year survival in pancreatic cancer trial

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxNOXh6U1JLNGhOdlVUMjNnZ1ZuNmlwU0UtQmRzY2c5TXVTMEptTnRYV1gzcndIMEw3SGFISkhTNkkxQTZMQnZVT3ZJZE5ha2k1MG1sYVgwU1ZNakpyNEtmek5rQ3JuX1k2NDdlb0JXQzBIQ2dWNWR3eVFZOXlrQVVkNHQ0NlItM3lBaTlKc2VkYmxBeHlVdmNBbTByUi1SYm1PUFNCYWN5b0d6SnZXZGtnNHJn?oc=5" target="_blank">Combination therapy doubles one-year survival in pancreatic cancer trial</a>  <font color="#6f6f6f">Drug Discovery News</font>

Read Full StoryMore like this
Truqap combination approved in the US as first and only targeted treatment for PTEN-deficient metastatic hormone-sensitive prostate cancer
AstraZenecageneral

Truqap combination approved in the US as first and only targeted treatment for PTEN-deficient metastatic hormone-sensitive prostate cancer

<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxPeWpGZ3ZJVjM5ZWExaWtiUlJLUkZVbWpWbW01dzRrUldvbGQyVFluM0kxNnhEMHlyalBLZE54ZERkRUpRS2EzbEpFQzZBa3FQM0NxRkRXU1hKODBjUFBpenR6Q3FBcHlfbHg0bnF2aTVDMkV6RVJoU2ZPcFl3Z1JsVFB6SnV0NzQzeDBOVWZoV0VXakNQNjF6V0VVQjByaUFvOUlIWGxtWXBJaUk?oc=5" target="_blank">Truqap combination approved in the US as first and only targeted treatment for PTEN-deficient metastatic hormone-sensitive prostate cancer</a>  <font color="#6f6f6f">AstraZeneca</font>

Read Full StoryMore like this
New Chemotherapy-Free Immunotherapy Combination for Follicular Lymphoma Listed on the PBS
PR Newswireworld

New Chemotherapy-Free Immunotherapy Combination for Follicular Lymphoma Listed on the PBS

<a href="https://news.google.com/rss/articles/CBMi3gFBVV95cUxQZ0VEeEdicWFGdHJTcDhQQ1JrTEw3YllicDFZQWZETm1PV3Vqa3lFNVlGcU4yN3JGLVU2blRHQmxCZHp1YlhBdmEyV3JucWgyLUh0Y09hWjYyalo5MkozeXlnRlFpT091RmtzS2ZZNHRzZEdDRmFYQlJ0bVJ1Z25SdUtZZFVXd3VQVEEwOWIyQVZaNTNoNlZrM1JLVDBQX21VN0x6WFdWb2N0cG9PaHlwZE9uVlNtaHpQVlJnQmpVSEN1S0pHRnNyN2E5UjN4MnZaU1VYejU4eTVqQVlScnc?oc=5" target="_blank">New Chemotherapy-Free Immunotherapy Combination for Follicular Lymphoma Listed on the PBS</a>  <font color="#6f6f6f">PR Newswire</font>

Read Full StoryMore like this
Roswell Park-Led Study Shows Promise for New Targeted Combination in People With Relapsed AML
Roswell Park Comprehensive Cancer Centergeneral

Roswell Park-Led Study Shows Promise for New Targeted Combination in People With Relapsed AML

<a href="https://news.google.com/rss/articles/CBMi2AFBVV95cUxNSEdvS1ppclp6eklqYlRucTl0WjNPQ0x3b0dSTmQ1Ry1PWWtFeGhvRW8zYXVWZ2hmQzFjU3BqdExHWnFMX0dNSUNmM1FLZXZKYmF6ejB1UTZqdHFRUHFFUGN4cW8xM2RkQ1d5eFFVMUExSGFkZmpmOEpycjlLc2tfbmRjMThqOUctT3pOdnlPQk1DUnlIMGpiNDY5eXZaWkxqbWhVSkRCdDVMZ2lCMGJqUF9leWZjN09HNmRvbFR4MzdmbVI5SFEwZGlkdHpnVG1iWlhmbVUzNng?oc=5" target="_blank">Roswell Park-Led Study Shows Promise for New Targeted Combination in People With Relapsed AML</a>  <font color="#6f6f6f">Roswell Park Comprehensive Cancer Center</font>

Read Full StoryMore like this
Looking Ahead: Combinations, New Targets, and the Path to Long-Term Survival
OncLivegeneral

Looking Ahead: Combinations, New Targets, and the Path to Long-Term Survival

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxNc2dvUHFva3BTT1V2TUVDanhIeE02ekFMWmN1UGpHMWpvYVNEQThRX1FvMTdyemdPYlR1b3lybldTSlJPUG53VjFQbkt2dGdfeVM0Vm9xbTFnYk1fYlRTaHZUZEI5MTYyTEctMjR6OGdwYnU3VzBFMy14ckQwckdld1k5OE95d0ZQTy13VldaUXdEcjlyQVFPY2hpMnFaVFZvN2FrUA?oc=5" target="_blank">Looking Ahead: Combinations, New Targets, and the Path to Long-Term Survival</a>  <font color="#6f6f6f">OncLive</font>

Read Full StoryMore like this
EMA Broadens Use of Targeted Combinations in Blood Cancers
Medscapegeneral

EMA Broadens Use of Targeted Combinations in Blood Cancers

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxQeUIwdEJOYXJOU2swaGJmV3FaYkhZMFc1NngtTlhpOHViTC1oTFBGbEVLdFJsbnBMQklGV1lpVlNpdUswbkFoaDZuYWw0STZaaXBFVlpLamFsQkFOVGdGSGRoNHN5UVY3cjBJdHlENGMxTXhHTmQxUHdrb1Z1Y2UzMlF4MUJEQWFOX2E0WkhfWWN5QTgxUFBVTUNJWW5hejcwMnBrdg?oc=5" target="_blank">EMA Broadens Use of Targeted Combinations in Blood Cancers</a>  <font color="#6f6f6f">Medscape</font>

Read Full StoryMore like this
Glioblastoma treatment boosted by new drug combination strategy
Drug Target Reviewgeneral

Glioblastoma treatment boosted by new drug combination strategy

<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxOeklHak0tckhzQmdxTDJPWUhmWjM1MmI2U1VBOW9ja0d6RzNVa0w0SmRsdUpZTGJfYjdaQnExRDFkaFNCZDR0WFlXY2xoR1ZHTWkyblNGYkp6Y25FUDc3WlFwU0NhbncydnNEZDBRbVBlODlrMV9HQ2FSbW5pSkZYWFFKLXFKZjBHSkNWSGpuYjdicGFGalNaTlV3WUVuQkFreXdCTUQ4VHFqQnpwSWl0Xw?oc=5" target="_blank">Glioblastoma treatment boosted by new drug combination strategy</a>  <font color="#6f6f6f">Drug Target Review</font>

Read Full StoryMore like this
New drug combination targets cancer and senescent cells while extending lifespan in old mice
EurekAlert! Science News Releasesgeneral

New drug combination targets cancer and senescent cells while extending lifespan in old mice

<a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE00dTQzWW1UMlVYUnFhTFY1NFZTbWc4dHpoU3BMMTRBTHQweEpnampIT2hINE9RcFlvOEpfWWI5cjduNDNqWDdjX2M5b1d6dWMzWkNBVDlXNDVDY0pr?oc=5" target="_blank">New drug combination targets cancer and senescent cells while extending lifespan in old mice</a>  <font color="#6f6f6f">EurekAlert! Science News Releases</font>

Read Full StoryMore like this
Combination of immunotherapy and targeted therapy improves survival for patients with advanced colorectal cancer
UCLAworld

Combination of immunotherapy and targeted therapy improves survival for patients with advanced colorectal cancer

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxObzFXdU1GMkVqTkNSRjN1VnBxYXpINGR4bVY5cm5ucUc5N1dhS1h3aVVZWkM1djJtQk9kNE51b2Q4WkR2amdDeFIwZVBRMkJMUmV2cFJZaDlMTGdRbWR4N0VOWXhWdnA0TmJyNktnaDNvSEgwdEF2RVVFWWJHZ1QwdDY1UnFqaGo3eVAwTWdkUmZSWnIyLV8tZGhiaHpmdEl6NUdVSkFmcw?oc=5" target="_blank">Combination of immunotherapy and targeted therapy improves survival for patients with advanced colorectal cancer</a>  <font color="#6f6f6f">UCLA</font>

Read Full StoryMore like this
New drug combo for relapsed neuroblastoma shows promise in the lab
BioTechniquesgeneral

New drug combo for relapsed neuroblastoma shows promise in the lab

<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxQSll6OEQwNEVDV21RSXNyelBOUk1ZaDdKUU00MDdHaV9qNWtLQ0ZBVHREU2xBcWZUVFgwM29qODdxaHhoUnFhcVpOOGF2Z211ZXJ5bVhJcGNiQTNqb3U0QlFDb2M2MG84NVRFVExzXzhyS3VjRXlyYnhqeHcyTTFlZk5OQnpCTV9xMEJUaU9WMmVfYWQxVzVQX3pkLTJGMXRXTWNFcWhiZGF3aExlbHpqMzQxZw?oc=5" target="_blank">New drug combo for relapsed neuroblastoma shows promise in the lab</a>  <font color="#6f6f6f">BioTechniques</font>

Read Full StoryMore like this
AstraZeneca's ceralasertib-Imfinzi drug combo misses survival target in lung cancer trial
Reutersworld

AstraZeneca's ceralasertib-Imfinzi drug combo misses survival target in lung cancer trial

<a href="https://news.google.com/rss/articles/CBMi5wFBVV95cUxOSVc2Z3Rwc2tKRXNpN2lIZE1RTW5fSUMzTmVxcHBjVGtubUN0alRvT2dGOWc4X2hlcE44QWtCc0Fta3BsVWlXV2FsaGI1emdzZGxjbDdVNXFmSzJVYnRzU1FHbXVOZGNXajlQeE5LdUdkWVpLdjBRSDYzMXo2Q1ZMb1U1dENISWpiNzlwdGhtanRuRUE5ZkdRbDlVdDc4c2NERU5SaXVXNl9QLVpISjc0Tmk3aXVYY2N2LXZuQ0hzdzhPX2hGbGJnZWt5aFJvdUhNTzNFNGZjUktoNTh5MVliUUpONl9ydjQ?oc=5" target="_blank">AstraZeneca's ceralasertib-Imfinzi drug combo misses survival target in lung cancer trial</a>  <font color="#6f6f6f">Reuters</font>

Read Full StoryMore like this
FDA Approves Targeted Combination Therapy for BRCA2-Mutated Prostate Cancer
Pharmacy Timesgeneral

FDA Approves Targeted Combination Therapy for BRCA2-Mutated Prostate Cancer

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxOODMtLVhlMlQxeE9jZ3EwOERUaDhaMXZUc1c4VXJMNGtmdWtYd0dsT280czE4YUhaZFVQaHlkc3lRYkM2MjVXaFV6UkU5SkZzTlVPTHNPR0ZSb2dtQ2ZGRXJyVGhocDdmWHJRSTBnTVI0TFdITGYyQWlrQnBMRmQyUXBaTS1LUDBhMEJNUDZ6TFJQVmkxdXNKak9PTkpGZ09XNHNxQVZfTUJNRnh5T1BB?oc=5" target="_blank">FDA Approves Targeted Combination Therapy for BRCA2-Mutated Prostate Cancer</a>  <font color="#6f6f6f">Pharmacy Times</font>

Read Full StoryMore like this
Chronic lymphocytic leukaemia: a new targeted ‘combination’ for first-line treatment
Il Sole 24 OREgeneral

Chronic lymphocytic leukaemia: a new targeted ‘combination’ for first-line treatment

<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxPMGlGRTRkZXluQjkzNHJ5dmNnNzVObVVsZ3l2QVc5NFgtX1BBUVFaTjhoOElXdlp5RlhKVzJfdHhBWmJhQ2JkZFdkLVdCb3UtQ2lfVmdhSnRPaEw2VFZ2X2NkXzc1dEloaWdNVElwT09nVXJRMzMySHFseGZpQTZBYTFoekJmOHFpTUttYXJiTk5aT1QtNVI0U1hzQUZndllSRHVmQWlDVmtLQXRtdHFPejdJUlhXTkQ4NmQzbjMwcFVGdTYy?oc=5" target="_blank">Chronic lymphocytic leukaemia: a new targeted ‘combination’ for first-line treatment</a>  <font color="#6f6f6f">Il Sole 24 ORE</font>

Read Full StoryMore like this
The Evolving Treatment Options For CLL, From 'Watchful Waiting' To New Targeted Combinations
SurvivorNettech

The Evolving Treatment Options For CLL, From 'Watchful Waiting' To New Targeted Combinations

<a href="https://news.google.com/rss/articles/CBMi5AFBVV95cUxPUDhSN2s0dWxNeTYzTl9aWWFqVDZUbGhFSHhfQ1Y2d0xSZkxQazZPM2cwZ2Zna1g1STl2cGlhWjFkUzA4OGphWkpkX0RtTml3eWRsQWJ4TnRhV190ZlFyUjhEcGJTdndkdW42NkRJRFotbWFiZnBNaWNZbHlybUFOc2wxbUdhbGE5TElYQ19fTmd3NU4zdUw1c1BmdG9vWkZaYlg0Mm9OZUVvUW02NTgyTURjbTdQaU9tZG1QU2xSMlBOdWVJSUZscm5sUENFaktrbGtaT1BrRG9JUE9yVjJzUUd3NVk?oc=5" target="_blank">The Evolving Treatment Options For CLL, From 'Watchful Waiting' To New Targeted Combinations</a>  <font color="#6f6f6f">SurvivorNet</font>

Read Full StoryMore like this
NCCN Guidelines in nccRCC Weigh New Data for Combinations
Targeted Oncologygeneral

NCCN Guidelines in nccRCC Weigh New Data for Combinations

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxOaWQwYWhURzJweF8wdmdPVVpxSnNkT0x2a2NKRFRfTm8xdGpUaHhtUVJZVEpKN0R5LUxFX1A4M1hlVnFnVVVIWkpwb0RQUTl6UmNMYkd6WndHV1BsVVdEUGVGTHJTcnRrblphT2JLUWJNVWpkMXdkZGdqcmNfR2QzZ25sU0FRWWRINmVnUFdmdE9SRWl6?oc=5" target="_blank">NCCN Guidelines in nccRCC Weigh New Data for Combinations</a>  <font color="#6f6f6f">Targeted Oncology</font>

Read Full StoryMore like this
FDA Approves Daraxonrasib for Pancreatic Cancer: What Patients Need To Know
Memorial Sloan Kettering Cancer Centergeneral

FDA Approves Daraxonrasib for Pancreatic Cancer: What Patients Need To Know

<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxQVW44aHFtT0xweVk4WjItWElHNnA4RU1EbFBUUmZhTGEyakJFRGtpdVlLQmprQVFzeTNlZ2hURzFMV2ZNZjkzd25PRGk3MWdLdXhxaXRWRDdoM2VLTS1VWm1FQjRpSDRPQ2NuM2dkRklaQnY5N1RKQTZtNjF2Y0ZxVXE1T0E4bHZoamZuSmc3dWxhcWVDMlJQMUxoOWZMVXNrUFQ1QXBB?oc=5" target="_blank">FDA Approves Daraxonrasib for Pancreatic Cancer: What Patients Need To Know</a>  <font color="#6f6f6f">Memorial Sloan Kettering Cancer Center</font>

Read Full StoryMore like this
Promising New Treatment for Myelofibrosis Blood Cancer Using a Combination Targeted Therapy
Memorial Sloan Kettering Cancer Centergeneral

Promising New Treatment for Myelofibrosis Blood Cancer Using a Combination Targeted Therapy

<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxNSEEzMVpib05MM1FXZWs1WF9uMTdMSDcwN0VPdm96N3RrakxfME4tQzFCVkpZaUpyUzdvekJYOWxmOVNmZFQwS0lNbEd2aUVfaHBEUmVWdmlUa0g1MkxVd3g0ZXZtY253YmV0d09KY0xob2c2QWVTWGZxdVBHUl9xNU9pTHBBWGF6SEM3UUNvVVlqVGFKbURObHNCbUswZE5YUUc2OVFJLS0wbF92cVNtUkR2cG80TEk?oc=5" target="_blank">Promising New Treatment for Myelofibrosis Blood Cancer Using a Combination Targeted Therapy</a>  <font color="#6f6f6f">Memorial Sloan Kettering Cancer Center</font>

Read Full StoryMore like this
Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma
The New England Journal of Medicinegeneral

Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5nOGFEQ095YTdHVGVqQTlybWkyVUh5eHoyU0Itd21aTWFMOHN0V2QteWE0aGdUZ29zSWZVSnJOUEUtZi15U0NLQ2J4ek5xTU5OQmtIZThQSzU2cHh1MGFn?oc=5" target="_blank">Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma</a>  <font color="#6f6f6f">The New England Journal of Medicine</font>

Read Full StoryMore like this
Combination targeted treatment produces lasting remissions in people with resistant aggressive B-cell lymphoma
National Cancer Institute (.gov)general

Combination targeted treatment produces lasting remissions in people with resistant aggressive B-cell lymphoma

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxPQWRTVUdPS0dBeV9FS2RBeDJqbjViSUFzck5lUzM1dFZoUjE4d0lpbmF4ZHR6WS10MlJwQkk3b0E2aE90dXFpZ2tyTURtQnlNVXpnYmRPaEpyWEg5T1EyYXpvVlFLM19XX18yNHVxTUVDa2RVSnVMTFlXN2xobmJIMThrRmJ6YnItb3pZNzljYVFFNGZYR19QQWVvcHg?oc=5" target="_blank">Combination targeted treatment produces lasting remissions in people with resistant aggressive B-cell lymphoma</a>  <font color="#6f6f6f">National Cancer Institute (.gov)</font>

Read Full StoryMore like this
Perspectives on cancer therapy—synthetic lethal precision medicine strategies, molecular mechanisms, therapeutic targets and current technical challenges
Naturetech

Perspectives on cancer therapy—synthetic lethal precision medicine strategies, molecular mechanisms, therapeutic targets and current technical challenges

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5pWGZ6N25aYTNsSE9TNlAtMmJDT1JZNEhBcmtRR0k5WGw4UDlmRjJPX3RRSUdFX21iM0VueUlLVmQwZXZnT0NNSjB0MlZMX3o5RkpvTkt3YTcwd1VSUTBB?oc=5" target="_blank">Perspectives on cancer therapy—synthetic lethal precision medicine strategies, molecular mechanisms, therapeutic targets and current technical challenges</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Discovering anticancer drug target combinations via network-informed signaling-based approach
Naturegeneral

Discovering anticancer drug target combinations via network-informed signaling-based approach

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBFRzI4bFNBVzNuUVhhaHI2aHFGOGgtUDBBOEJBS1M3Y1QtSXlZa243dzlLR0RTYXQ4b0YzWVkzakJJTms5Ry1ZYnJmaFQwZzFIVEdKMEVEQjZIMU0xSFlj?oc=5" target="_blank">Discovering anticancer drug target combinations via network-informed signaling-based approach</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Combination of dual-targeted therapies and chemotherapy shows high response rates in BRAF-mutated metastatic colorectal cancer
UT MD Andersongeneral

Combination of dual-targeted therapies and chemotherapy shows high response rates in BRAF-mutated metastatic colorectal cancer

<a href="https://news.google.com/rss/articles/CBMijgJBVV95cUxNMnpGV0xsQVlLV0dJQ2ZLRG1XZVhRVnRrcWc4VllVWVQySW8zMkRIOVhJZGVTMUdqaUwyNDJBbHFZV1hhdDNfdnM1aTFielJmM1pYZl84SW5DSml3SnpTODBHdHVENUpNcFNhNk5rMGVTc1BkRzR2a3p3UU0zRGszY1pWQ2JMbnRacDdJT1RHaWFDclNXczB0N2NiazVGcEplbnRoODZYcDlYSldZX1FNaDQ2T09mdWk3RGg4VTZ0djg5RjVtMm1kNGUwTnctQ3ZiLUNfZjFPdE40M3hWWGFzSzU3QlVEaWNWOGtaRHd5ak1uVXJiTmFMTkljTHYtLUdvNU5XLWhmXzBnTHRxMGc?oc=5" target="_blank">Combination of dual-targeted therapies and chemotherapy shows high response rates in BRAF-mutated metastatic colorectal cancer</a>  <font color="#6f6f6f">UT MD Anderson</font>

Read Full StoryMore like this
New Combination Immunotherapy Targets Melanoma and Breast Cancer with Promising Results
Inside Precision Medicineworld

New Combination Immunotherapy Targets Melanoma and Breast Cancer with Promising Results

<a href="https://news.google.com/rss/articles/CBMi3AFBVV95cUxNMFNGNUp1Z0t4OEJYZmU0SkpGU0tBYzZhbElwUE9TbGVlZl9HaXhNMVBOelEyZ1pyLUlHZUVEMUJKZVAyX1VLS1N1LTAwd0tXbmxtLV9Rclo1QmxhRTNlblpNa1VIR1VHeXYzVUxtX3BjX05GbXQ0bVZmTDdqc2pqeHdfVHNTOGpXaEZManZyb3k2cjMyaGQtUnB5VTVHTGZkdXVEODgwVWNHaEktSDBiX0x1REc1R05xMlQwYUZ1Z3pibmlWNktYM1laZW1NN25fdWRhMFF2LS1Td1lv?oc=5" target="_blank">New Combination Immunotherapy Targets Melanoma and Breast Cancer with Promising Results</a>  <font color="#6f6f6f">Inside Precision Medicine</font>

Read Full StoryMore like this
FDA Clears Novel Combination Trial for Recurrent Glioblastoma
Targeted Oncologygeneral

FDA Clears Novel Combination Trial for Recurrent Glioblastoma

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxNTk9RcDFKYlZPLUNHcERTdHhSM1BEODRPYnhfYklhQUtiSFEtREhzcmhFYUlOazZ4WjRKR0R2V1RadGpXcmpsaDNrZGNGYkFYalFuTXpFMVJDLWxnRXNqZTVSUXh5OE9Rck1ia2lJMnpjeHU5Q0FfdEZaQUdsLUllbFVMYWNVR0t0NFdOWVlKWW14UUxHZGhVbjVn?oc=5" target="_blank">FDA Clears Novel Combination Trial for Recurrent Glioblastoma</a>  <font color="#6f6f6f">Targeted Oncology</font>

Read Full StoryMore like this
New research reveals how combining viruses with targeted drugs can boost cancer-killing immune responses
The Institute of Cancer Researchworld

New research reveals how combining viruses with targeted drugs can boost cancer-killing immune responses

<a href="https://news.google.com/rss/articles/CBMi5gFBVV95cUxPdzBxak85Q0tacVlEeWxBNFdwcXhFSWNkQURJZXFidnBjLWx2UHFWVkY0NDk4UTI3ZU90NW1CdXVhejNKNU1SSkh0SHVKRHhGRDlBTkw5MDNTODExd3VYR3JKSDNpNm1SbHJ5VVBSMERwVmdkY3VQY0JPbGFsWWo2dm42U1FCR1RMQXRVTWdHLWczS043NC1fdG5Ld18yMFJKSnpfU3QzVnF0SVJIZ0VaSXpGaFpqdXhxSGxHYlVjZG5qZHRYdEEyYlgwQ3B1djFwR2VVc2kzcWFrTC02cHFMT3NDRTgyUQ?oc=5" target="_blank">New research reveals how combining viruses with targeted drugs can boost cancer-killing immune responses</a>  <font color="#6f6f6f">The Institute of Cancer Research</font>

Read Full StoryMore like this
New drug combo targets PRMT5 to fight deadly cancers
Drug Target Reviewgeneral

New drug combo targets PRMT5 to fight deadly cancers

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxQNzhvVmcyZ0VuYVc0bjNSNV9ULTdJTmZxZ1JCdVZhb0hPdUZfTUJZTDRWLXZ5MWRFcWhoZWpCVWU1WU9ITXVSSU1jNDZYQU1qMFE2TDdMWHRjQ2phV3h6R1JCYkFlSWI1ZmpCTFA0Qmd6YWEyT0MzNERjdGlFRHJuSWpJN2hYRnYyMEdMTEpfTjZNZVpDTG9GTjljeks0Q0w4bnc?oc=5" target="_blank">New drug combo targets PRMT5 to fight deadly cancers</a>  <font color="#6f6f6f">Drug Target Review</font>

Read Full StoryMore like this
"New targeted combination" — Live Google News Trends & Headlines